Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

[Prevalence of peripheral neuropathy among primary care type 2 diabetic patients].

Ibarra CT, Rocha Jde J, Hernández RO, Nieves RE, Leyva RJ.

Rev Med Chil. 2012 Sep;140(9):1126-31. doi: 10.4067/S0034-98872012000900004. Spanish.

2.

Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with Type 2 diabetes in Korea.

Won JC, Kwon HS, Kim CH, Lee JH, Park TS, Ko KS, Cha BY.

Diabet Med. 2012 Sep;29(9):e290-6. doi: 10.1111/j.1464-5491.2012.03697.x.

PMID:
22519862
4.

The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran.

Kiani J, Moghimbeigi A, Azizkhani H, Kosarifard S.

Arch Iran Med. 2013 Jan;16(1):17-9. doi: 013161/AIM.006.

5.

The prevalence of peripheral neuropathy in newly diagnosed patients with non-insulin-dependent diabetes mellitus.

Weerasuriya N, Siribaddana S, Wijeweera I, Dissanayeka A, Wijesekera J, Fernando DJ.

Ceylon Med J. 1998 Mar;43(1):19-21.

PMID:
9624839
6.

Prevalence and characteristics of diabetic polyneuropathy in Passo Fundo, South of Brazil.

Tres GS, Lisbôa HR, Syllos R, Canani LH, Gross JL.

Arq Bras Endocrinol Metabol. 2007 Aug;51(6):987-92.

7.

Subclinical diabetic neuropathy: a common complication in Saudi diabetics.

Akbar DH, Mira SA, Zawawi TH, Malibary HM.

Saudi Med J. 2000 May;21(5):433-7.

PMID:
11500676
8.

The prevalence of diabetic peripheral neuropathy in an outpatient setting.

Mimi O, Teng CL, Chia YC.

Med J Malaysia. 2003 Oct;58(4):533-8.

9.

Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors.

Janghorbani M, Rezvanian H, Kachooei A, Ghorbani A, Chitsaz A, Izadi F, Amini M.

Acta Neurol Scand. 2006 Dec;114(6):384-91.

PMID:
17083338
11.
12.

[Association between neuropathy and peripheral vascular insufficiency in patients with diabetes mellitus type 2].

Millán-Guerrero RO, Vásquez C, Isaís-Millán S, Trujillo-Hernández B, Caballero-Hoyos R.

Rev Invest Clin. 2011 Nov-Dec;63(6):621-9. Spanish.

PMID:
23650675
13.

Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India.

Ashok S, Ramu M, Deepa R, Mohan V.

J Assoc Physicians India. 2002 Apr;50:546-50.

PMID:
12164406
14.

Prevalence of factors predisposing to foot complication and their relation to other risks.

Sattaputh C, Potisat S, Jongsareejit A, Krairittichai U, Pooreesathian K.

J Med Assoc Thai. 2012 Aug;95(8):1013-20.

PMID:
23061304
15.

[Evaluation of the four simple methods in the diagnosis of diabetic peripheral neuropathy].

Jia WP, Shen Q, Bao YQ, Lu JX, Li M, Xiang KS.

Zhonghua Yi Xue Za Zhi. 2006 Oct 17;86(38):2707-10. Chinese.

PMID:
17199983
16.

A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.

Papanas N, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Maltezos E.

Exp Clin Endocrinol Diabetes. 2008 Feb;116(2):135-8. Epub 2007 Dec 20.

PMID:
18095233
18.

Symptoms and complications of adult diabetic patients in a family practice.

Konen JC, Curtis LG, Summerson JH.

Arch Fam Med. 1996 Mar;5(3):135-45.

PMID:
8620254
19.

Prevalence and clinical implications of painful diabetic peripheral neuropathy in type 2 diabetes: results from a nationwide hospital-based study of diabetic neuropathy in Korea.

Kim SS, Won JC, Kwon HS, Kim CH, Lee JH, Park TS, Ko KS, Cha BY.

Diabetes Res Clin Pract. 2014 Mar;103(3):522-9. doi: 10.1016/j.diabres.2013.12.003. Epub 2013 Dec 25.

PMID:
24438877
20.

Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis.

Pappachan JM, Sebastian J, Bino BC, Jayaprakash K, Vijayakumar K, Sujathan P, Adinegara LA.

Postgrad Med J. 2008 Apr;84(990):205-10. doi: 10.1136/pgmj.2007.064048.

PMID:
18424578

Supplemental Content

Support Center